<DOC>
	<DOCNO>NCT03017573</DOCNO>
	<brief_summary>SCANDARE prospective biobanking study tumor ( +/- node ) , plasma blood sample different time point ovarian , triple negative breast head neck cancer patient . This study allow identify new molecular and/or immunological biomarkers associate clinical biological feature tumor . All patient receive standard treatment accord stage disease usual procédures .</brief_summary>
	<brief_title>Prospective Biobanking Study Ovarian , Breast Head Neck Cancer Patients Aiming Better Understand Link Between Molecular Alterations Tumor Itself , Its Microenvironment Immune Response ( SCANDARE )</brief_title>
	<detailed_description>Patients blood +/- tumor sample follow time : 1. eligible surgery : - surgery ( blood + tumor node ) - surgery ( blood ) - cycle 1 adjuvant chemotherapy ( blood + tumor biopsie node possible ) - cycle 2 adjuvant chemotherapy ( blood ) - progression ( blood + tumor biopsie node possible ) 2. eligible neoadjuvant chemotherapy : - neoadjuvant therapy ( blood + tumor biopsie node ) - neoadjuvant therapy ( post cycle 1 ) ( blood ) - time surgery ( blood + tumor node ) - cycle 1 adjuvant chemotherapy ( blood + tumor biopsie node ) - cycle 2 adjuvant chemotherapy ( blood ) - progression ( blood + tumor biopsie node )</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Triple Negative Breast Neoplasms</mesh_term>
	<criteria>1 . Tumor type : 1 . Newly diagnose treatmentnaïve ovarian cancer patient eligible surgery neoadjuvant chemotherapy 2 . Newly diagnose treatmentnaïve triplenegative breast cancer patient eligible surgery neoadjuvant chemotherapy 3 . Newly diagnose treatmentnaïve head neck cancer patient eligible surgery 2 . Male female patient ≥ 18 year age 3 . Signed informed consent 1 . Male female patient ≤18 year old 2 . Patients psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule 3 . Individually deprived liberty place authority tutor 4 . Patients affiliate Social Security System</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Immunological biomarkers</keyword>
	<keyword>molecular profil</keyword>
	<keyword>Circulating tumor DNA ( ctDNA )</keyword>
</DOC>